Nov 16, 2020- Abbott achieves top industry scores in governance/economic and social performance, earns more than triple the average industry score in its industry sector- Company recognized for sustainability on DJSI for 16 consecutive years- Abbott to introduce its 2030 sustainability plan later this year- Nov 10, 2020-- Radiofrequency ablation is a minimally invasive procedure to deactivate nerves associated with pain for up to one year-- The launch of Abbott's IonicRF Generator adds a promising option for the 50 million Americans currently living with chronic pain
-
Nov 2, 2020- The EnSite™ X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures- System offers electrophysiologists a new platform of options to provide consistent performance, regardless of the patient’s cardiac anatomy
- Oct 30, 2020-- Considered as the industry's equivalent of the Nobel Prize in biopharmaceutical and medical technology research, Prix Galien USA honored MitraClip as the Best Medical Technology for 2020-- The groundbreaking MitraClip therapy has positively impacted the lives of more than 100,000 people globally living with mitral regurgitation, or a leaky heart valve